A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study

BACKGROUND: Adequate anticoagulation is prerequisite for effective hemodialysis to prevent clotting in the extracorporeal circuit. We aimed providing first data on the efficacy and safety of the low-molecular-weight heparin certoparin in this setting. METHODS: Multicenter, open-label, 8-week trial....

Descripción completa

Detalles Bibliográficos
Autores principales: Dorsch, Oliver, Krieter, Detlef H, Lemke, Horst-Dieter, Fischer, Stefan, Melzer, Nima, Sieder, Christian, Bramlage, Peter, Harenberg, Job
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508880/
https://www.ncbi.nlm.nih.gov/pubmed/22742742
http://dx.doi.org/10.1186/1471-2369-13-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508880/
https://www.ncbi.nlm.nih.gov/pubmed/22742742
http://dx.doi.org/10.1186/1471-2369-13-50

Ejemplares similares